Fingerprint
Dive into the research topics of 'Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): A multicentre, randomised controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): A multicentre, randomised controlled trial
Elvira O.G. Van Vliet, Tobias A.J. Nijman, Ewoud Schuit, Karst Y. Heida, Brent C. Opmeer, Marjolein Kok, Wilfried Gyselaers, Martina M. Porath, Mallory Woiski, Caroline J. Bax, Kitty W.M. Bloemenkamp, Hubertina C.J. Scheepers, Yves Jacquemyn, Erik Van Beek, Johannes J. Duvekot, Maureen T.M. Franssen, Dimitri N. Papatsonis, Joke H. Kok, Joris A.M. Van Der Post, Arie Franx
*Corresponding author for this work
- Utrecht University
- Stanford University
- Academic Medical Centre
- East Limburg Hospital
- Hasselt University
- Maxima Medical Centre
- University Medical Center, Radboud
- Vrije University Medical Center
- Leiden University Medical Centre
- Maastricht University
- University of Antwerp
- St. Antonius Ziekenhuis
- Erasmus Medical Centre
- University Medical Center Groningen
- Amphia Hospital
- The Robinson Research Institute
- University of Adelaide
- South Australian Health And Medical Research Institute
Research output: Contribution to journal › Article › peer-review
63
Citations
(Scopus)